Streetbeat News

Price Targets

QTWO

Morgan Stanley analyst James Faucette has maintained an Equal-Weight rating on Q2 Holdings (NYSE:QTWO) and raised the price target from $29 to $34.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 1:14 pm

PTLO

Morgan Stanley analyst Brian Harbour has maintained an Equal-Weight rating on Portillos (NASDAQ:PTLO) and raised the price target from $19 to $20.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 1:11 pm

PEN

Morgan Stanley analyst Kallum Titchmarsh has maintained an Equal-Weight rating on Penumbra (NYSE:PEN) and lowered the price target from $265 to $240.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 1:08 pm

MDLZ

Morgan Stanley analyst Pamela Kaufman has maintained an Overweight rating on Mondelez International (NASDAQ:MDLZ) but lowered the price target from $82 to $74.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 1:05 pm

MC

Morgan Stanley analyst Ryan Kenny has maintained an 'Underweight' rating on Moelis (NYSE:MC) and lowered the price target from $39 to $38.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 1:03 pm

MCHP

Morgan Stanley analyst Joseph Moore has maintained an Overweight rating on Microchip Technology (NASDAQ:MCHP) but lowered the price target from $96 to $90.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 1:02 pm

IQV

Morgan Stanley analyst Tejas Savant has maintained an Overweight rating on IQVIA Holdings (IQV) but lowered the price target from $240 to $225.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 1:00 pm

ALKT

In the last quarter, Alkami Technology (NASDAQ:ALKT) received 4 bullish analyst ratings. The company's average 12-month price target is $22.5, an increase of 9.76% from the previous average price target of $20.50.

Portfolio Pulse from Benzinga Insights

November 03, 2023 | 1:00 pm

IONS

Morgan Stanley analyst Michael Ulz maintains an Equal-Weight rating on Ionis Pharmaceuticals (NASDAQ:IONS) and raises the price target from $45 to $48.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:59 pm

CFLT

Canaccord Genuity analyst Kingsley Crane has downgraded Confluent (NASDAQ:CFLT) from Buy to Hold and set a price target of $26.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 12:56 pm